Skip to main content

Find Clinical Trials

Home
Conditions
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS

Clinical trial condition

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS

Explore clinical trials studying Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS trial results

Recruiting

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

NCT02203903

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +11 more
Locations: Childrens National Medical Center Washington D.C., District of Columbia, United States

Tania Jain, MD Baltimore, Maryland, United States

View Trial Details